Wed, February 2, 2022

Raghuram Selvaraju Maintained (AVXL) at Strong Buy with Increased Target to $42 on, Feb 2nd, 2022

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Anavex Life Sciences Corp." (AVXL) at Strong Buy with Increased Target from $39 to $42 on, Feb 2nd, 2022.

Raghuram, nor any peers, have made any analyst calls on AVXL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30